Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00696228 · ClinicalTrials.gov registry record · Phase 3
High Fat Diet: Oxidative and Cardiovascular Effects
A Phase 3 study, sponsored by Vanderbilt University.
- Completed
- Registry status
- Phase 3
- Development phase
- 144
- Enrollment target
NCT00696228 is a Phase 3 study that has completed, run by Vanderbilt University. The registered enrollment target is 144 participants.
The verdict
NCT00696228, a Phase 3 study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 144 participants
- Enrollment target
Study Summary
To test the effects of a modified Atkins high fat diet on endothelial function, insulin resistance and energy balance.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT MUFA
- DIETARY_SUPPLEMENT PUFA
- DIETARY_SUPPLEMENT SFA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2008-08 |
| Est. Completion | 2013-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00696228
The ClinicalTrials.gov registry entry for NCT00696228 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00696228 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00696228 about?
NCT00696228 is a clinical study titled "High Fat Diet: Oxidative and Cardiovascular Effects". To test the effects of a modified Atkins high fat diet on endothelial function, insulin resistance and energy balance.
What is the current status of trial NCT00696228?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 144 participants. The study started on 2008-08. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00696228?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), MUFA (DIETARY_SUPPLEMENT), PUFA (DIETARY_SUPPLEMENT), SFA (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00696228?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.